INSERT INTO `announcement` (announcement_id,announcement_title,announcement_description,announcement_img,announcement_file_0,announcement_file_1,announcement_file_2,announcement_file_3,announcement_postdate,announcement_expire,created_at,updated_at) VALUES (22,Five-year interval is safe for prostate cancer screening, research shows,The PSA blood test checks the level of prostate-specific antigen, a marker for prostate cancer. In Europe, only Lithuania routinely screens men for prostate cancer based on their PSA levels, as the test has historically been seen as insufficiently reliable.

The German study, presented at the European Association of Urology (EAU) Congress in Paris, involved over 12,500 men aged between 45-50 taking part in the ongoing PROBASE trial, which is testing different prostate cancer screening protocols.

The research has also been accepted for publication in European Urology.

PROBASE is recruiting men aged 45 and splitting them into three groups based on their initial PSA test. Men with a PSA level of under 1.5 nanograms per milliliter (ng/ml) are deemed low risk and followed up with a second test after five years. Men with a PSA level between 1.5–3 ng/ml are deemed intermediate risk and followed up in two years. Those with a PSA level over 3 ng/ml are seen as high risk and given an MRI scan and biopsy.

Of over 20,000 men recruited to the trial and deemed low risk, 12,517 have now had their second PSA test at age 50. The researchers found that only 1.2% of these (146 in total) had high levels of PSA (over 3 ng/ml) and were referred for an MRI and biopsy. Only 16 of these men were subsequently found to have cancer—just 0.13% of the total cohort.,announcementimage9501571482024-04-1011:17:55.jpg,,,,,2024-04-01,2024-04-10,2024-04-10 00:00:00,2024-04-10 00:00:00);
INSERT INTO `announcement` (announcement_id,announcement_title,announcement_description,announcement_img,announcement_file_0,announcement_file_1,announcement_file_2,announcement_file_3,announcement_postdate,announcement_expire,created_at,updated_at) VALUES (24,Myths about PSA tests and prostate cancer screening,The main screening tool for prostate cancer is the PSA test, which measures levels of a protein called prostate-specific antigen (PSA) in the blood. In the past, some experts have suggested that PSA testing caused more harm than good, saying it can lead to unnecessary biopsies and therapies for cancers that actually don't need to be treated.

Today, the PSA test should be used as one part of the tool kit for finding cancer and identifying which cancers should be treated, Dr. Vickers says. An expert in health outcomes related to the detection and treatment of prostate cancer, Dr. Vickers spoke at the 2024 Annual Meeting of the American Association for Cancer Research.

In his presentation, "Seven Myths About PSA and Prostate Cancer Screening," Dr. Vickers sought to raise awareness about the best way to use the PSA test. Here, we recap those myths.,coverimg20240410072213546308783.jpg,,,,,2024-04-06,2024-04-10,2024-04-10 00:00:00,2024-04-10 00:00:00);
INSERT INTO `announcement` (announcement_id,announcement_title,announcement_description,announcement_img,announcement_file_0,announcement_file_1,announcement_file_2,announcement_file_3,announcement_postdate,announcement_expire,created_at,updated_at) VALUES (25,TEST announcement,Some people sense an increasing reliance on glasses and wonder if their eyes have become "lazy".

Our eyes work in much the same way as an auto-focus camera. A flexible lens inside each eye is controlled by muscles that let us focus on objects in the distance (such as a footy scoreboard) by relaxing the muscle to flatten the lens. When the muscle contracts it makes the lens steeper and more powerful to see things that are much closer to us (such as a text message).

From the age of about 40, the lens in our eye progressively hardens and loses its ability to change shape. Gradually, we lose our capacity to focus on near objects. This is called "presbyopia" and at the moment there are no treatments for this lens hardening.

Optometrists correct this with prescription glasses that take the load of your natural lens. The lenses allow you to see those up-close images clearly by providing extra refractive power.

Once we are used to seeing clearly, our tolerance for blurry vision will be lower and we will reach for the glasses to see well again.,announcementimage21104983882024-04-1013:41:30.jpg,announcementfile015605031412024-04-0916:23:17.pdf,,,,2024-04-09,2024-04-10,2024-04-10 00:00:00,2024-04-10 00:00:00);
INSERT INTO `announcement` (announcement_id,announcement_title,announcement_description,announcement_img,announcement_file_0,announcement_file_1,announcement_file_2,announcement_file_3,announcement_postdate,announcement_expire,created_at,updated_at) VALUES (32,A whistleblower claims that Boeing’s 787 Dreamliner is flawed. The FAA is investigating,Federal authorities say they’re investigating Boeing after a whistleblower repeatedly raised concerns with two widebody jet models, and claimed the company retaliated against him.

Whistleblower Sam Salehpour, a Boeing engineer, alleges that Boeing took shortcuts when manufacturing its 777 and 787 Dreamliner jets, and that the risks could become catastrophic as the airplanes age. The New York Times was first to report the whistleblower complaint.

His formal complaint to the Federal Aviation Administration, filed in January and made public on Tuesday, is not specific to the newer 737 Max jet that has been grounded twice by the Federal Aviation Administration.

Salehpour on Tuesday said his complaint raises “two quality issues that may dramatically reduce the life of the planes.”,coverimg202404100742132092143539.jpg,,,,,2024-04-02,2024-04-10,2024-04-10 00:00:00,2024-04-10 00:00:00);
